Cargando…
Prone position ventilation and femoro‐femoral veno‐venous extracorporeal membrane oxygenation for COVID‐19 treatment
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which causes coronavirus disease 2019 (COVID‐19), has resulted in significant morbidity and mortality worldwide. Approximately 5% of COVID‐19 patients who suffer from pneumonia develop critical respiratory failure. Here, we report the cas...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737602/ https://www.ncbi.nlm.nih.gov/pubmed/33343904 http://dx.doi.org/10.1002/rcr2.700 |
_version_ | 1783622970938228736 |
---|---|
author | Maeda, Akiko Nabeya, Daijiro Nagano, Hiroaki Yagi, Nobuhito Miyagi, Tadayoshi Kishaba, Tomoo |
author_facet | Maeda, Akiko Nabeya, Daijiro Nagano, Hiroaki Yagi, Nobuhito Miyagi, Tadayoshi Kishaba, Tomoo |
author_sort | Maeda, Akiko |
collection | PubMed |
description | Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which causes coronavirus disease 2019 (COVID‐19), has resulted in significant morbidity and mortality worldwide. Approximately 5% of COVID‐19 patients who suffer from pneumonia develop critical respiratory failure. Here, we report the case of a healthy 52‐year‐old man who had respiratory failure owing to SARS‐CoV‐2 infection and was treated using femoro‐femoral veno‐venous extracorporeal membrane oxygenation (VV‐ECMO) and prone position ventilation (PPV). After this treatment, his blood oxygen levels, chest high‐resolution computed tomography findings, and clinical parameters significantly improved. He was decannulated from VV‐ECMO on day 6 and finally extubated on day 11. To our knowledge, this is the first reported case of SARS‐CoV‐2‐associated acute respiratory distress syndrome that was successfully treated with a combination of femoro‐femoral VV‐ECMO and PPV. |
format | Online Article Text |
id | pubmed-7737602 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley & Sons, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-77376022020-12-18 Prone position ventilation and femoro‐femoral veno‐venous extracorporeal membrane oxygenation for COVID‐19 treatment Maeda, Akiko Nabeya, Daijiro Nagano, Hiroaki Yagi, Nobuhito Miyagi, Tadayoshi Kishaba, Tomoo Respirol Case Rep Case Reports Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which causes coronavirus disease 2019 (COVID‐19), has resulted in significant morbidity and mortality worldwide. Approximately 5% of COVID‐19 patients who suffer from pneumonia develop critical respiratory failure. Here, we report the case of a healthy 52‐year‐old man who had respiratory failure owing to SARS‐CoV‐2 infection and was treated using femoro‐femoral veno‐venous extracorporeal membrane oxygenation (VV‐ECMO) and prone position ventilation (PPV). After this treatment, his blood oxygen levels, chest high‐resolution computed tomography findings, and clinical parameters significantly improved. He was decannulated from VV‐ECMO on day 6 and finally extubated on day 11. To our knowledge, this is the first reported case of SARS‐CoV‐2‐associated acute respiratory distress syndrome that was successfully treated with a combination of femoro‐femoral VV‐ECMO and PPV. John Wiley & Sons, Ltd 2020-12-15 /pmc/articles/PMC7737602/ /pubmed/33343904 http://dx.doi.org/10.1002/rcr2.700 Text en © 2020 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Case Reports Maeda, Akiko Nabeya, Daijiro Nagano, Hiroaki Yagi, Nobuhito Miyagi, Tadayoshi Kishaba, Tomoo Prone position ventilation and femoro‐femoral veno‐venous extracorporeal membrane oxygenation for COVID‐19 treatment |
title | Prone position ventilation and femoro‐femoral veno‐venous extracorporeal membrane oxygenation for COVID‐19 treatment |
title_full | Prone position ventilation and femoro‐femoral veno‐venous extracorporeal membrane oxygenation for COVID‐19 treatment |
title_fullStr | Prone position ventilation and femoro‐femoral veno‐venous extracorporeal membrane oxygenation for COVID‐19 treatment |
title_full_unstemmed | Prone position ventilation and femoro‐femoral veno‐venous extracorporeal membrane oxygenation for COVID‐19 treatment |
title_short | Prone position ventilation and femoro‐femoral veno‐venous extracorporeal membrane oxygenation for COVID‐19 treatment |
title_sort | prone position ventilation and femoro‐femoral veno‐venous extracorporeal membrane oxygenation for covid‐19 treatment |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737602/ https://www.ncbi.nlm.nih.gov/pubmed/33343904 http://dx.doi.org/10.1002/rcr2.700 |
work_keys_str_mv | AT maedaakiko pronepositionventilationandfemorofemoralvenovenousextracorporealmembraneoxygenationforcovid19treatment AT nabeyadaijiro pronepositionventilationandfemorofemoralvenovenousextracorporealmembraneoxygenationforcovid19treatment AT naganohiroaki pronepositionventilationandfemorofemoralvenovenousextracorporealmembraneoxygenationforcovid19treatment AT yaginobuhito pronepositionventilationandfemorofemoralvenovenousextracorporealmembraneoxygenationforcovid19treatment AT miyagitadayoshi pronepositionventilationandfemorofemoralvenovenousextracorporealmembraneoxygenationforcovid19treatment AT kishabatomoo pronepositionventilationandfemorofemoralvenovenousextracorporealmembraneoxygenationforcovid19treatment |